Literature DB >> 13609

Amylase, hepatic enzymes and bilirubin in serum of chronic alcoholics.

G Skude, J Wadstein.   

Abstract

The serum concentration of bilirubin and the activities of aspartate aminotransferase (ASAT, GOT), alanine aminotransferase (ALAT, GPT), gamma-glutamyltransferase (GT), total amylase and pancreatic isoamylase have been determined in serum of 182 male chronic alcoholics. Twelve per cent had abnormally high levels of bilirubin, 73% increased activity of S-ASAT, 50% increased S-ALAT, and 69% increased S-GT. The highest values were often found after 5-20 years of well documented alcoholism. Some patients with alcoholism of more than 20 years' duration displayed a slight tendency towards normalization of the activities. For all parameters the scatter around the mean was greater in the patients than in the controls. Patients who had had attacks of delirium showed slightly higher S-ASAT and S-ALAT than other alcoholics. Determination of S-ALAT and S-bilirubin did not add to the cases with abnormal laboratory tests demonstrated by the combination of S-ASAT and S-GT. In 14 patients the above mentioned parameters were within normal limits, even though severe alcoholism had lasted for many years. Isoamylase determination disclosed 20% to have decreased activity of pancreatic isoamylases in serum, whereas only 6% had low total serum amylase activity.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 13609     DOI: 10.1111/j.0954-6820.1977.tb15654.x

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  9 in total

Review 1.  Clinical significance in alcoholic patients of commonly encountered laboratory test results.

Authors:  G J Magarian; L M Lucas; K L Kumar
Journal:  West J Med       Date:  1992-03

Review 2.  Is serum gamma-glutamyltransferase a misleading test?

Authors:  R Penn; D J Worthington
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-12

Review 3.  Early identification of alcohol abuse: 1. Critical issues and psychosocial indicators for a composite index.

Authors:  H A Skinner; S Holt; Y Israel
Journal:  Can Med Assoc J       Date:  1981-05-01       Impact factor: 8.262

4.  Treatment of alcoholic liver disease.

Authors:  Thomas H Frazier; Abigail M Stocker; Nicole A Kershner; Luis S Marsano; Craig J McClain
Journal:  Therap Adv Gastroenterol       Date:  2011-01       Impact factor: 4.409

5.  [Drunkenness in traffic in Geneva: occasional abuse or alcoholism?].

Authors:  W Michiels; R La Harpe
Journal:  Soz Praventivmed       Date:  1996

6.  Influence of hepatic impairment on pharmacokinetics of the human GLP-1 analogue, liraglutide.

Authors:  Anne Flint; Khalil Nazzal; Pawel Jagielski; Charlotte Hindsberger; Milan Zdravkovic
Journal:  Br J Clin Pharmacol       Date:  2010-12       Impact factor: 4.335

Review 7.  Clinical pathology of alcohol.

Authors:  V Marks
Journal:  J Clin Pathol       Date:  1983-04       Impact factor: 3.411

Review 8.  Early identification of alcohol abuse: 2: Clinical and laboratory indicators.

Authors:  S Holt; H A Skinner; Y Israel
Journal:  Can Med Assoc J       Date:  1981-05-15       Impact factor: 8.262

9.  Circulating Extracellular Vesicles and Their miR "Barcode" Differentiate Alcohol Drinkers With Liver Injury and Those Without Liver Injury in Severe Trauma Patients.

Authors:  Akiko Eguchi; Niklas Franz; Yoshinao Kobayashi; Motoh Iwasa; Nils Wagner; Frank Hildebrand; Yoshiyuki Takei; Ingo Marzi; Borna Relja
Journal:  Front Med (Lausanne)       Date:  2019-02-25
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.